| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7f75780245ab029ad042060276ad22a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-524 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q5-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-38 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-38 |
| filingDate |
2011-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32e9ca379bc6c248755c02faf93f5ede
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eea0ecd28f25b6ae319026b0b2b4a165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c46e9064fed4be3a1bec498d6cf02e88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6fe700418547fbd1660c0cca46fba1b |
| publicationDate |
2013-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-102011088944-A1 |
| titleOfInvention |
Active ingredient combinations of silver compounds and one or more physiologically acceptable hydroxamic acid and cosmetic or dermatological preparations containing such drug combinations |
| abstract |
Active ingredient combinations comprising a) one or more physiologically acceptable hydroxamic acids and b) silver or silver compounds |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111491602-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2018388437-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4046611-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11690833-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2760840-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019125792-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2018390439-B2 |
| priorityDate |
2011-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |